|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
JST138774811 |
003 |
DE-627 |
005 |
20240625235030.0 |
007 |
cr uuu---uuuuu |
008 |
240115s2017 xx |||||o 00| ||eng c |
035 |
|
|
|a (DE-627)JST138774811
|
035 |
|
|
|a (JST)26156900
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Weyl, E. Glen
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Pricing Institutions and the Welfare Cost of Adverse Selection
|
264 |
|
1 |
|c 2017
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
520 |
|
|
|a To mitigate adverse selection in insurance markets, individuals are often mandated to buy at least a baseline plan, but may choose to opt into a premium plan. In some markets, such as US health exchanges, each plan is responsible for the full expenses of those who buy it ("total pricing"). In other markets, such as the privately supplied "Medigap" top-ups to traditional government-provided Medicare, premium providers are only responsible for the incremental expenses they top up ("incremental pricing"). For parameter values calibrated to health exchanges, the shift from total to incremental pricing reduces the welfare loss from adverse selection by an order of magnitude.
|
540 |
|
|
|a Copyright © 2017 American Economic Association
|
650 |
|
4 |
|a Economics
|x Economic disciplines
|x Financial economics
|x Finance
|x Financial analysis
|x Risk management
|x Adverse selection
|
650 |
|
4 |
|a Business
|x Business operations
|x Commerce
|x Pricing
|x Prices
|
650 |
|
4 |
|a Business
|x Business operations
|x Commerce
|x Pricing
|x Prices
|x Market prices
|
650 |
|
4 |
|a Economics
|x Economic disciplines
|x Financial economics
|x Financial markets
|x Insurance markets
|
650 |
|
4 |
|a Economics
|x Economic disciplines
|x Financial economics
|x Insurance
|x Insurance expenses
|x Insurance premiums
|
650 |
|
4 |
|a Applied sciences
|x Technology
|x Instrumentation
|x Calibration
|
650 |
|
4 |
|a Economics
|x Microeconomics
|x Economic costs and benefits
|x Economic costs
|
650 |
|
4 |
|a Health sciences
|x Health care industry
|x Health care administration
|x Health care finance
|x Health insurance
|
650 |
|
4 |
|a Economics
|x Microeconomics
|x Economic costs and benefits
|x Economic costs
|x Average cost
|
650 |
|
4 |
|a Economics
|x Microeconomics
|
655 |
|
4 |
|a research-article
|
700 |
1 |
|
|a Veiga, André
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t American Economic Journal: Microeconomics
|d American Economic Association
|g 9(2017), 2, Seite 139-148
|w (DE-627)579824438
|w (DE-600)2452644-7
|x 19457685
|7 nnns
|
773 |
1 |
8 |
|g volume:9
|g year:2017
|g number:2
|g pages:139-148
|
856 |
4 |
0 |
|u http://www.jstor.org/stable/26156900
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_JST
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_26
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a GBV_ILN_39
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a GBV_ILN_63
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a GBV_ILN_69
|
912 |
|
|
|a GBV_ILN_70
|
912 |
|
|
|a GBV_ILN_90
|
912 |
|
|
|a GBV_ILN_100
|
912 |
|
|
|a GBV_ILN_110
|
912 |
|
|
|a GBV_ILN_187
|
912 |
|
|
|a GBV_ILN_224
|
912 |
|
|
|a GBV_ILN_252
|
912 |
|
|
|a GBV_ILN_285
|
912 |
|
|
|a GBV_ILN_374
|
912 |
|
|
|a GBV_ILN_702
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2007
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2009
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2011
|
912 |
|
|
|a GBV_ILN_2014
|
912 |
|
|
|a GBV_ILN_2015
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a GBV_ILN_2020
|
912 |
|
|
|a GBV_ILN_2021
|
912 |
|
|
|a GBV_ILN_2026
|
912 |
|
|
|a GBV_ILN_2027
|
912 |
|
|
|a GBV_ILN_2044
|
912 |
|
|
|a GBV_ILN_2050
|
912 |
|
|
|a GBV_ILN_2056
|
912 |
|
|
|a GBV_ILN_2057
|
912 |
|
|
|a GBV_ILN_2061
|
912 |
|
|
|a GBV_ILN_2107
|
912 |
|
|
|a GBV_ILN_2111
|
912 |
|
|
|a GBV_ILN_2129
|
912 |
|
|
|a GBV_ILN_2190
|
912 |
|
|
|a GBV_ILN_2470
|
912 |
|
|
|a GBV_ILN_2937
|
912 |
|
|
|a GBV_ILN_2941
|
912 |
|
|
|a GBV_ILN_2949
|
912 |
|
|
|a GBV_ILN_2950
|
912 |
|
|
|a GBV_ILN_4012
|
912 |
|
|
|a GBV_ILN_4035
|
912 |
|
|
|a GBV_ILN_4037
|
912 |
|
|
|a GBV_ILN_4046
|
912 |
|
|
|a GBV_ILN_4112
|
912 |
|
|
|a GBV_ILN_4125
|
912 |
|
|
|a GBV_ILN_4126
|
912 |
|
|
|a GBV_ILN_4242
|
912 |
|
|
|a GBV_ILN_4251
|
912 |
|
|
|a GBV_ILN_4305
|
912 |
|
|
|a GBV_ILN_4306
|
912 |
|
|
|a GBV_ILN_4307
|
912 |
|
|
|a GBV_ILN_4322
|
912 |
|
|
|a GBV_ILN_4323
|
912 |
|
|
|a GBV_ILN_4324
|
912 |
|
|
|a GBV_ILN_4325
|
912 |
|
|
|a GBV_ILN_4326
|
912 |
|
|
|a GBV_ILN_4335
|
912 |
|
|
|a GBV_ILN_4346
|
912 |
|
|
|a GBV_ILN_4393
|
912 |
|
|
|a GBV_ILN_4700
|
951 |
|
|
|a AR
|
952 |
|
|
|d 9
|j 2017
|e 2
|h 139-148
|